S. Giassas

Pemetrexed versus erlotinib in pretreated patients with advanced non–small cell lung cancer: A Hellenic Oncology Research Group (HORG) randomized phase 3 study

D. Mavroudis, V. Georgoulias, G. Samonis, 2013, Cancer.

TCCAAATGAGCTGGCAAGTG TCAGAGCCTGTGTTTCTACCAA TCCCAAACACTCAGTGAAACAAA TGGTCTCACAGGACCACTGATT Exon 19 EGFR AAATAATCAGTGTGATTCGTGGAG GAGGCCAGTGCTGTCTCTAAGG GAGGCCAGTGCTGTCTCTAAGG TGTGGAGATGAGCAGGGTCT Exon 21 EGFR GCAGCGGGTTACATCTTCTTTC GCTCAGAGCCTGGCATGAA CAGCTCTGGCTCACACTACCAG CATCCTCCCCTGCATGTGT Exon

D. Mavroudis, V. Georgoulias, G. Samonis, 2013 .

A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumours

S. Agelaki, V. Georgoulias, M. Marselos, 2007, British Journal of Cancer.

Pooled Analysis of Elderly Patients with Non-small Cell Lung Cancer Treated with Front Line Docetaxel/Gemcitabine Regimen: The Hellenic Oncology Research Group Experience

S. Agelaki, V. Georgoulias, I. Boukovinas, 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Continuous Administration of Daily Low-Dose Temozolomide in Pretreated Patients with Advanced Non-Small Cell Lung Cancer: A Phase II Study

V. Georgoulias, A. Kalykaki, N. Vardakis, 2009, Oncology.

Breast cancer, locally advanced and metastatic

L. Holmberg, O. Nanni, S. Barni, 2012 .